Grensyn Pharmaceutique Private Limited

Develops and manufactures pharmaceutical products using innovative drug delivery technologies for Indian and international companies.

2016 | Kanchipuram, Tamil Nadu (India) | Inactive
Last Updated: May 04, 2024

Grensyn Pharmaceutique Profile

Key Indicators

  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 9 Year, 2 Days
  • Last Filing with ROC 31 Mar 2018
  • Revenue Growth %
  • Ebitda
  • Net Worth
  • Total Assets 9.90%

About Grensyn Pharmaceutique

Grensyn Pharmaceutique Private Limited (GPPL) is Strike Off company established on 12 Feb 2016 with its office registered at Kanchipuram, Tamil Nadu, India and has been running since 9 Year, 2 Days with a paid up capital of 0.10 M. According to MCA records, 2 Directors are linked to this company as of 04 May 2024.

Company Details

  • Location

    Kanchipuram, Tamil Nadu, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24232TN2016PTC104103

  • Company No.

    104103

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    12 Feb 2016

  • Date of AGM

    26 Sep 2018

  • Date of Balance Sheet

    31 Mar 2018

  • Listing Status

    Unlisted

  • ROC Code

    Roc Chennai

Industry

Pharma

Who are the key members and board of directors at Grensyn Pharmaceutique?

Board Members (2)

Name Designation Appointment Date Status
Durairaj Madhumathi Country flag representing In Director 29-Jul-2019 Current
Vasudewan Maheswaran Country flag representing In Director 12-Feb-2016 Current

Financial Performance of Grensyn Pharmaceutique.

Grensyn Pharmaceutique Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
Revenue from Operations
Total Assets
9.90%
Profit or Loss
Net Worth
EBITDA

What is the Ownership and Shareholding Structure of Grensyn Pharmaceutique?

In 2018, Grensyn Pharmaceutique had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Grensyn Pharmaceutique?

Unlock and access historical data on people associated with Grensyn Pharmaceutique, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Grensyn Pharmaceutique, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Grensyn Pharmaceutique's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Grensyn Pharmaceutique

Recent activity within the organization

  • Director Appointment

    Durairaj Madhumathi was appointed as a Director was appointed as a Director on 29 Jul 2019 & has been associated with this company since 5 years 6 months .

    29 Jul 2019

  • Annual General Meeting

    Grensyn Pharmaceutique Private Limited last Annual general meeting of members was held on 26 Sep 2018 as per latest MCA records.

    26 Sep 2018

  • Balance Sheet

    Grensyn Pharmaceutique Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Chennai.

    31 Mar 2018

  • Director Appointment

    Vasudewan Maheswaran was appointed as a Director was appointed as a Director on 12 Feb 2016 & has been associated with this company since 9 years 2 days .

    12 Feb 2016

  • Company Incorporation

    Grensyn Pharmaceutique Private Limited was registered on 12 Feb 2016 with Roc Chennai & aged 9 years 2 days as per MCA records.

    12 Feb 2016

Frequently asked questions

  • Grensyn Pharmaceutique Private Limited was incorporated on 12 Feb 2016.

  • The authorized share capital of Grensyn Pharmaceutique Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Currently 2 directors are associated with Grensyn Pharmaceutique Private Limited.

    • Durairaj Madhumathi
    • Vasudewan Maheswaran
  • As per Ministry of Corporate Affairs (Mca), the registered address of Grensyn Pharmaceutique Private Limited is N0 4 14Th Street Balaji Nagar, Adambakkam, Chennai, Tamil Nadu, India, 600088.

  • The corporate identification number (CIN) of Grensyn Pharmaceutique Private Limited is U24232TN2016PTC104103 and the company number is 104103 as per Ministry of Corporate Affairs (MCA).

  • The most recent Balance Sheet for Grensyn Pharmaceutique Private Limited was filed with the ROC on 31 Mar 2018.

People also Viewed

Similar Companies Based on Drug Formulation & Development